Summary
Lumbar CSF indoleacetic acid (IAA) was higher in patients with cirrhosis of the liver than in controls. It was also higher in CSF of patients in coma than in those with hepatic cirrhosis but not in coma. There was a strong correlation (r=0.89, p<0.01) between the grade of hepatic coma and CSF IAA. These data indicate that there is an association between elevated CNS tryptamine metabolism and hepatic coma. How far changes in the metabolism of tryptamine and other trace amines are relevant to the induction of hepatic coma or are simply a reflection of advanced liver dysfunction is unclear.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson, G. M., Purdy, W. C. A liquid chromatographic-fluorometric system for the analysis of indoles in physiological samples. Anal. Chem.51, 283–286 (1979).
Åsberg, M., Bertilsson, L., Tuck, D., Cronholm, B., Sjöqvist, F. Indoleamine metabolites in cerebrospinal fluid of depressed patients before and during treatment with nortriptyline. Clin. Pharmacol. Ther.14, 277–286 (1973).
Baldessarini, R. J., Fischer, J. E. Substitute and alternative neurotransmitters in neuropsychiatrie illness. Arch. Gen. Psychiat.34, 958–964 (1977).
Cangiano, G., Calcateria, V., Cascino, A., Capocaccia, L. Bound and free tryptophan plasma levels in hepatic encephalopathy. Rendic. Gastroenterol.8, 186–189 (1976).
Capocaccia, L., Cangiano, C., Cascino, A., Calcateria, V., Cardelli, P., Fanelli, F. R. Influence of phenylethanolamine on octopamine plasma determination in hepatic encephalopathy. Clin. Chim. Acta93, 371–376 (1979).
Checkley, S. A., Oon, M. C. H., Rodnight, R., Murphy, M. P., Williams, R. S., Birley, J. L. T. Urinary excretion of dimethyltryptamine in liver disease. Amer. J. Psychiat.136, 439–441 (1979).
Faraj, B. A., Bowen, P. A., Isaacs, J. W., Rudman, D. Hypertyraminemia in cirrhotic patients. New Engl. J. Med.294, 1360–1364 (1976).
Hirayama, C. Tryptophan metabolism in liver disease. Clin. Chim. Acta32, 191–197 (1971).
Hutson, D. G., Ono, J., Dombro, R. S., Levi, J. V., Livingstone, A., Zeppa, R. A longitudinal study of tryptophan involvement in hepatic coma. Amer. J. Surg.137, 235–239 (1979).
James, J. H., Escourrou, J., Fischer, J. E. Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis. Science200, 1395–1397 (1978).
Jellinger, K., Riederer, P., Rausch, W. D., Kothbauer, P. Brain monoamines in hepatic encephalopathy and other types of metabolic coma. J. Neural Transm., Suppl. 14, pp. 103–120. Wien-New York: Springer. 1978.
Knell, A. J., Davidson, A. R., Williams, R., Kantamaneni, B. D., Curzon, G. Dopamine and serotonin metabolism in hepatic encephalopathy. Brit. Med. J.I, 549–551 (1974).
Lal, S., Aronoff, A., Garelis, E., Sourkes, T. L., Young, S. N., de la Vega, G. E. Cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid, lactic acid, and pH before and after probenecid in hepatic coma. Clin. Neurol. Neurosurg.77, 142–154 (1974).
Lal, S., Young, S. N., Sourkes, T. L. 5-Hydroxytryptamine and hepatic coma. LancetII, 979–980 (1975).
Manghani, K. K., Lunzer, M. R., Billing, B. H., Sherlock, S. Urinary and serum octopamine in patients with portal-systemic encephalopathy. LancetII, 943–946 (1975).
Oldendorf, W. H., Braun, L. D. 3H-Tryptamine and3H-water as diffusible internal standards for measuring brain extraction of radio-labeled substances following carotid injection. Brain. Res.113, 219–224 (1976).
Olsson, R., Roos, B. E. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease. Nature219, 502–503 (1968).
Ono, J., Hutson, D. G., Dombro, R. S., Levi, J. U., Livingstone, A., Zeppa, R. Tryptophan and hepatic coma. Gastroenterol.74, 196–200 (1978).
Smith, A. R., Rossi-Fanelli, F., Ziparo, V., James, J. H., Perelle, B. A., Fischer, J. E. Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann. Surg.187, 343–350 (1978).
Soeters, P. B., Fischer, J. E. Insulin, Glucago, aminoacid imbalance, and hepatic encephalopathy. LancetII, 880–882 (1976).
Warsh, J. J., Coscina, D. V., Godse, D. D., Chan, P. W. Dependence of brain tryptamine formation on tryptophan availability. J. Neurochem.32, 1191–1196 (1979).
Webster, L. T., Davidson, C. S. The effect of sodium glutamate on hepatic coma. J. Clin. Invest.35, 191–199 (1956).
Young, S. N., Lal, S., Sourkes, T. L., Feldmuller, F., Aronoff, A., Martin, J. B. Relationship between tryptophan in serum and CSF and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration. J. Neurol. Neurosurg. Psychiat.38, 322–330 (1975).
Young, S. N., Etienne, P., Sourkes, T. L. The relationship between rat brain and cisternal CSF tryptophan concentrations. J. Neurol. Neurosurg. Psychiat.39, 239–243 (1976).
Young, S. N., Anderson, G. M., Gauthier, S., Purdy, W. C.: The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid. J. Neurochem. (in press, 1980 a).
Young, S. N., Anderson, G. M., Purdy, W. C. Indoleamine metabolism in rat brain studied through measurements of tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in cerebrospinal fluid. J. Neurochem.34, 308–315 (1980 b).
Young, S. N., Gauthier, S., Anderson, G. M., Purdy, W. C.: Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J. Neurol. Neurosurg. Psychiat. (in press, 1980 c).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Young, S.N., Lal, S. CNS tryptamine metabolism in hepatic coma. J. Neural Transmission 47, 153–161 (1980). https://doi.org/10.1007/BF01250597
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01250597